Hikma Could Consider Exit Strategy For Generics Business
Also Provides Update On CEO Search As Recruitment Process Continues
Hikma says all options are on the table for its beleaguered generics business, with an immediate sale unlikely but the door open for a longer-term exit strategy. Meanwhile, the firm has also offered an update on recruitment for a new CEO.